AIM Talking Points: CDC and FDA Identify Preliminary COVID-19 Vaccine Safety Signal for Persons Aged 65 Years and Older
This content is restricted to members only. Please login below.
What’s Happening at AIM February 7, 2022
This week's COVID-19 update from AIM Executive Director Claire Hannan includes updates on the Pfizer pediatric under 5 COVID vaccine rollout, information on the FDA IIS-medicare linkage data requests from…
FDA Authorized vs FDA Approved
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.
COVID-19 Update: February 21, 2022
AIM Members – Happy President's Day Weekend 😊
What’s Happening at AIM January 31, 2022
This week's COVID-19 update from AIM Executive Director Claire Hannan includes notes from last week's CDC distribution office hours, information on the FDA IIS-medicare linkage data requests from health plans,…
COVID-19 Update: January 30, 2022
Hope you are staying warm and cozy!! We didn’t get much snow but some of you did. Enjoy!!
COVID-19 Update: April 3, 2022
AIM Members - Happy Monday 😊
What’s Happening at AIM February 22, 2022
This week's COVID-19 update from AIM Executive Director Claire Hannan includes updates on the FDA considering a second COVID-19 booster, upcoming AIM events, notes from AIM/CDC listening sessions, and more!…
2022 AIM Leadership in Action Conference Presentations
View the session descriptions, presentations, and supplemental materials from the 2022 AIM Leadership in Action Conference.
2022 AIM Leadership in Action Conference
These presentations and accompanying resources were presented at the 2022 AIM Leadership in Action Conference. For any questions or additional information, please contact us.